Sobrero A - Search Results

1

Randomized trial of TAS-102 for refractory metastatic colorectal cancer.

Mayer RJ, Van Cutsem E, Falcone A, Yoshino T, Garcia-Carbonero R, Mizunuma N, Yamazaki K, Shimada Y, Tabernero J, Komatsu Y, Sobrero A, Boucher E, Peeters M, Tran B, Lenz HJ, Zaniboni A, Hochster H, Cleary JM, Prenen H, Benedetti F, Mizuguchi H, Makris L, Ito M, Ohtsu A; RECOURSE Study Group. Mayer RJ, et al. Among authors: sobrero a. N Engl J Med. 2015 May 14;372(20):1909-19. doi: 10.1056/NEJMoa1414325. N Engl J Med. 2015. PMID: 25970050 Free article. Clinical Trial.

2

A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients.

Nobile MT, Canobbio L, Sobrero A, Galligioni E, Vidili MG, Fassio T, Lo Re G, Rubagotti A, Sertoli MR, Rosso R. Nobile MT, et al. Among authors: sobrero a. Adv Exp Med Biol. 1988;244:213-8. doi: 10.1007/978-1-4684-5607-3_22. Adv Exp Med Biol. 1988. PMID: 3073656 Clinical Trial. No abstract available.

3

Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma.

Rosso R, Mazzei T, Sobrero A, Mini E, Cartei G, Conte P, Labianca R, Cartei F, Falcone A, Pancera G, et al. Rosso R, et al. Among authors: sobrero a. Eur J Cancer. 1994;30A(3):338-43. doi: 10.1016/0959-8049(94)90253-4. Eur J Cancer. 1994. PMID: 8204356 Clinical Trial.

4

Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study.

Aschele C, Guglielmi A, Frassineti GL, Milandri C, Amadori D, Labianca R, Vinci M, Tixi L, Caroti C, Ciferri E, Verdi E, Rosso R, Sobrero A. Aschele C, et al. Among authors: sobrero a. Br J Cancer. 1998;77(2):341-6. doi: 10.1038/bjc.1998.53. Br J Cancer. 1998. PMID: 9461008 Free PMC article. Clinical Trial.

5

New directions in the treatment of colorectal cancer: a look to the future.

Sobrero A, Kerr D, Glimelius B, Van Cutsem E, Milano G, Pritchard DM, Rougier P, Aapro M. Sobrero A, et al. Eur J Cancer. 2000 Mar;36(5):559-66. doi: 10.1016/s0959-8049(99)00314-7. Eur J Cancer. 2000. PMID: 10738119 Review.

6

Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.

Sobrero A, Zaniboni A, Frassineti GL, Aschele C, Guglielmi A, Giuliani R, Ravaioli A, Lanfranco C, Caroti C, Arnoldi E, Barni S, Gallo L, Pessi MA, Turci D, Cortesi E, Grossi F, Frontini L, Piazza E, Bruzzi P, Labianca R. Sobrero A, et al. Ann Oncol. 2000 Nov;11(11):1413-20. doi: 10.1023/a:1026527605389. Ann Oncol. 2000. PMID: 11142481 Free article. Clinical Trial.

7

Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy.

Douillard JY, Sobrero A, Carnaghi C, Comella P, Díaz-Rubio E, Santoro A, Van Cutsem E. Douillard JY, et al. Among authors: sobrero a. Ann Oncol. 2003;14 Suppl 2:ii7-12. doi: 10.1093/annonc/mdg723. Ann Oncol. 2003. PMID: 12810451 Free article. Review.

8

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.

Cassidy J, Tabernero J, Twelves C, Brunet R, Butts C, Conroy T, Debraud F, Figer A, Grossmann J, Sawada N, Schöffski P, Sobrero A, Van Cutsem E, Díaz-Rubio E. Cassidy J, et al. Among authors: sobrero a. J Clin Oncol. 2004 Jun 1;22(11):2084-91. doi: 10.1200/JCO.2004.11.069. J Clin Oncol. 2004. PMID: 15169795 Clinical Trial.

9

Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil.

Guglielmi A, Barni S, Zaniboni A, Pella N, Belvedere O, Beretta GD, Grossi F, Frontini L, Puglisi F, Labianca R, Sobrero A; Gruppo Italiano Studio Carcinomi Apparato Digerente. Guglielmi A, et al. Among authors: sobrero a. Br J Cancer. 2004 Oct 18;91(8):1428-33. doi: 10.1038/sj.bjc.6602176. Br J Cancer. 2004. PMID: 15381935 Free PMC article. Clinical Trial.

10

Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.

Sobrero A, Frassineti G, Falcone A, Dogliotti L, Rosso R, Di Costanzo F, Bruzzi P; INTACC. Sobrero A, et al. Br J Cancer. 2005 Jan 17;92(1):24-9. doi: 10.1038/sj.bjc.6602276. Br J Cancer. 2005. PMID: 15611795 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

296 results

Search Page